Figure-d (Figure D)
Ryaltris Spray, Metered
Product Images NDC 68462-659
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Ryaltris (NDC 68462-659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-f (Figure F)
Figure-g (Figure G)
Figure-j (Figure J)
Figure-m (Figure M)
Figure-a (Figure A)
This is a description of a purple dustcap with a spray nozzle unit included along with a finger rest for comfortable handling.*
Figure-b (Figure B)
This text appears to be information about a nasal spray product called Ryaltris. It contains oxymetazoline hydrochloride and mometasone furoate as active ingredients. The product is a nasal spray with 240 metered sprays and a fill weight of 31g.*
Figure-c (Figure C)
Figure-e (Figure E)
Figure-h (Figure H)
This is a description of a nasal spray product with the active ingredients Olopatadine hydrochloride and Mometasone furoate. It is a nasal spray with 665 mcg per spray, and the product contains 240 metered sprays with a net fill weight of 31 grams.*
Figure-i (Figure I)
This text appears to be a label or description for a nasal spray product called Ryaltris. The product contains 665 mcg/25 per spray and has a net fill weight of 31g. It comes in a container with 240 metered sprays. The NDC number for this product is 6846.*
Figure-k (Figure K)
This text provides information about a medication with National Drug Code (NDC) 6846, containing 665 mcg/25, with 240 metered sprays and a net fill weight of 31g. This product may be a nasal spray or inhaler based on the "Metered Sprays" information.*
Figure-l (Figure L)
This text contains information about a nasal spray called Ryaltris, which is a prescription medication containing olopatadine hydrochloride and mometasone furoate. Each spray delivers 665 mcg of olopatadine hydrochloride and 25 mcg of mometasone furoate. The product includes 240 metered sprays and has a net fill weight of 31 grams.*
Figure-n (Figure N)
Glenmarklogo (Glenmarklogo)
Glenmarklogo2 (Glenmarklogo2)
Image1 (Image1)
The text contains instructions for a nasal spray called RYALTRIS, including shaking the bottle before use, initial priming, repriming, recommended dosage, storage guidelines, and contact information for the manufacturer. It also provides details about the composition of the nasal spray, its administration, the number of metered sprays, and the net fill weight. It is manufactured by Glenmark Pharmaceuticals Inc. in the USA and is a product of India.*
Image2 (Image2)
The text provides detailed instructions for using a nasal spray product called Ryaltris containing olopatadine hydrochloride and mometasone furoate. It includes information on dosing instructions, priming the product, how to use it, clearing a blocked nozzle tip, storage recommendations, and safety tips. It is a prescription medication meant for intranasal use to relieve allergy symptoms. The product is distributed by Glenmark Pharmaceuticals Inc., USA.*
Structuremometasone (Structuremometasone)
Structureolopatadine (Structureolopatadine)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
